Patents Assigned to REGENERATIVE MEDICAL SOLUTIONS, INC.
  • Patent number: 10526576
    Abstract: Methods, kits, compositions, and systems are provided for culturing pluripotent stem cells to produce populations of cells comprising beta-like cells (e.g., pancreatic lineage, glucose-responsive, and/or insulin-producing). In particular, culture conditions are provided that result in the generation of beta-like cells from a starting culture of human pluripotent stem cells.
    Type: Grant
    Filed: November 26, 2018
    Date of Patent: January 7, 2020
    Assignee: REGENERATIVE MEDICAL SOLUTIONS, INC.
    Inventors: Xiaofang Xu, Jon Odorico, Erik Forsberg, Amber A. Mael
  • Patent number: 10138466
    Abstract: Methods, kits, compositions, and systems are provided for culturing pluripotent stem cells to produce populations of cells comprising beta-like cells (e.g., pancreatic lineage, glucose-responsive, and/or insulin-producing). In particular, culture conditions are provided that result in the generation of beta-like cells from a starting culture of human pluripotent stem cells.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: November 27, 2018
    Assignee: REGENERATIVE MEDICAL SOLUTIONS, INC.
    Inventors: Xiaofang Xu, Jon Odorico, Erik Forsberg, Amber A. Mael
  • Patent number: 9828634
    Abstract: Provided herein are systems and methods for identifying cell-specific differentiation markers. In particular, provided herein are systems and methods for generating induced pluripotent cells (IPS) from human cells, differentiating the IPS into differentiated cells, and identifying differentiation specific markers.
    Type: Grant
    Filed: January 22, 2016
    Date of Patent: November 28, 2017
    Assignee: REGENERATIVE MEDICAL SOLUTIONS, INC.
    Inventors: Xiaofang Xu, Jon Odorico, Erik Forsberg, Amber A. Mael, Guy Tagliavia
  • Patent number: 9765302
    Abstract: Methods, kits, compositions, and systems are provided for culturing pluripotent stem cells to produce populations of cells comprising beta-like cells (e.g., pancreatic lineage, glucose-responsive, and/or insulin-producing). In particular, culture conditions are provided that result in the generation of beta-like cells from a starting culture of human pluripotent stem cells.
    Type: Grant
    Filed: June 20, 2016
    Date of Patent: September 19, 2017
    Assignee: REGENERATIVE MEDICAL SOLUTIONS, INC.
    Inventors: Xiaofang Xu, Jon Odorico, Erik Forsberg, Amber A. Mael
  • Patent number: 9371516
    Abstract: Methods, kits, compositions, and systems are provided for culturing pluripotent stem cells to produce populations of cells comprising beta-like cells (e.g., pancreatic lineage, glucose-responsive, and/or insulin-producing). In particular, culture conditions are provided that result in the generation of beta-like cells from a starting culture of human pluripotent stem cells.
    Type: Grant
    Filed: September 18, 2015
    Date of Patent: June 21, 2016
    Assignee: REGENERATIVE MEDICAL SOLUTIONS, INC.
    Inventors: Xiaofang Xu, Jon Odorico, Erik Forsberg, Amber A. Mael